HanchorBio partners with WuXi Biologics for development and manufacturing of next-gen bi- and multi-functional fusion programmes

MS Pharma enters strategic partnership with Hetero Group

PhotonPharma adds Dr. William Warren to board

Mabwell reports first patient dosed with 7MW4911 in US trial

Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025

Avacta secures FDA clearance for second pre|CISION oncology programme

Guardant Health and Merck enter multi-year oncology diagnostics collaboration

Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis

EMA validates Daiichi Sankyo's ENHERTU plus pertuzumab application for first-line HER2 positive metastatic breast cancer

Immunovia gains California approval for PancreaSure and begins commercial rollout

Atossa Therapeutics' (Z)-endoxifen receives US FDA Orphan Drug Designation to treat Duchenne muscular dystrophy

Profusa launches Lumee tissue oxygen system for CRO market

OncoHost receives BIG Innovation Award in Health category

Hoth Therapeutics achieves European regulatory milestone for HT-001

Zydus Lifesciences acquires Agenus Inc's biologics manufacturing facilities, launches Zylidac Bio LLC in US